Other critical evidence
2022 ∙ Giorgia Sulis, Miranda Horn, Ray Borrow, Nicole E. Basta
A comparison of national vaccination policies to prevent serogroup B meningococcal disease
Download:
  • Meningococcal disease
2019 ∙ Robert L Zoma, Jenny A Walldorf, Felix Tarbangdo, Jaymin C Patel, Alpha Oumar Diallo
Evaluation of the Impact of Meningococcal Serogroup A Conjugate Vaccine Introduction on Second-Year-of-Life Vaccination Coverage in Burkina Faso
Download:
  • Burkina Faso
  • Meningococcal disease
2018 ∙ Reza Yaesoubi, Caroline Trotter, Caroline Colijn, Maziar Yaesoubi, Anaïs Colombini
The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study
Download:
  • Burkina Faso
  • Meningococcal disease
2015 ∙ Milagritos D. Tapia, Samba O. Sow, Fadima Cheick Haidara, Fatoumata Diallo, Moussa Doumbia
A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
Download:
  • Mali
  • Meningococcal disease
2015 ∙ Andromachi Karachaliou, Andrew J. K. Conlan, Marie-Pierre Préziosi, Caroline Trotter
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
Download:
  • Meningococcal disease